Tumor-associated pDCs stimulated by TGF-β express indoleamine 2,3-dioxygenase (IDO) to induce tolerance and employ ICOSL-mediated Treg differentiation to suppress immunity [57, 58]. The gene discussed is TGFB1; the disease is neoplasm.